BRKR Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

41.270

Open

40.440

VWAP

40.69

Vol

3.26M

Mkt Cap

6.26B

Low

39.690

Amount

132.70M

EV/EBITDA(TTM)

15.90

Total Shares

152.22M

EV

7.82B

EV/OCF(TTM)

58.18

P/S(TTM)

1.80

Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic solutions. The Company's segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). Its BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research and development solutions in chemical research fields. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and others.

Show More

Events Timeline

(ET)

2026-04-17

09:10:00

Bruker Corporation to Showcase New Spatial Biology Updates at 2026 AACR Meeting

2026-04-13 (ET)

2026-04-13

07:10:00

Bruker Corporation Launches New NMR Products and Solutions

2026-04-07 (ET)

2026-04-07

07:10:00

Bruker Accelerates Development of Photothermal AFM-IR Spectroscopy

2026-04-01 (ET)

2026-04-01

07:20:00

Bruker Corporation Appoints Thierry Bernard to Board of Directors

2026-03-31 (ET)

2026-03-31

13:10:00

PreOmics and Biognosys Win Patent Review

2026-03-30 (ET)

2026-03-30

07:20:00

Seer Secures Patent Review Support for Nanoparticle Technology

News

Newsfilter

04-17Newsfilter

Bruker Spatial Biology Unveils New Platforms at AACR 2026

Newsfilter

04-17Newsfilter

Bruker Launches MBT Easy T®Kit and Expands Libraries

Newsfilter

04-17Newsfilter

Bruker Launches MyGenius PRO® Molecular Diagnostics System in Europe

Yahoo Finance

04-17Yahoo Finance

Bruker's MBT Easy T® Kit Enhances Microbial Identification

Yahoo Finance

04-14Yahoo Finance

Bruker Unveils New NMR Products at Conference

Newsfilter

04-13Newsfilter

Bruker Corporation Unveils New NMR Products and Solutions

12 Analyst Rating

Wall Street analysts forecast BRKR stock price to rise

7 Buy

4 Hold

1 Sell

Moderate Buy

Current: 0.000

Low

40.00

Averages

52.18

High

60.00

Current: 0.000

Low

40.00

Averages

52.18

High

60.00

Barclays

Overweight

downgrade

$50 -> $45

AI Analysis

2026-04-14

Reason

Barclays

Price Target

$50 -> $45

AI Analysis

2026-04-14

downgrade

Overweight

Reason

Barclays lowered the firm's price target on Bruker to $45 from $50 and keeps an Overweight rating on the shares. The firm adjusted targets in the life science and diagnostic tools group as part of a Q1 preview. Barclays likes the setup for the sector but says it is "not without risk." Sentiment is at all-time lows and Barclays still believes in the "last-cut thesis (for the most part)," the analyst tells investors in a research note.

Guggenheim

Buy

downgrade

$58 -> $50

2026-03-30

Reason

Guggenheim

Price Target

$58 -> $50

2026-03-30

downgrade

Buy

Reason

Guggenheim lowered the firm's price target on Bruker to $50 from $58 and keeps a Buy rating on the shares. The firm adjusted models and forecasts for select companies in its diagnostics and life science tools coverage to reflect recent updates from the companies after meetings with management teams.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BRKR

Unlock Now

Valuation Metrics

The current forward P/E ratio for Bruker Corp (BRKR.O) is 15.22, compared to its 5-year average forward P/E of 25.86. For a more detailed relative valuation and DCF analysis to assess Bruker Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

25.86

Current PE

15.22

Overvalued PE

32.75

Undervalued PE

18.98

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

17.96

Current EV/EBITDA

16.47

Overvalued EV/EBITDA

21.90

Undervalued EV/EBITDA

14.01

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

3.17

Current PS

1.59

Overvalued PS

4.22

Undervalued PS

2.11

Financials

AI Analysis

Annual

Quarterly

Whales Holding BRKR

Needham Investment Management, LLC

Vaughan Nelson Investment Management, L.P.

Eversept Partners, L.P.

Edmond de Rothschild Asset Management (France)

Orbis Investment Management Limited

Samlyn Capital, LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Bruker Corp (BRKR) stock price today?

The current price of BRKR is 41.1 USD — it has increased 0.98

What is Bruker Corp (BRKR)'s business?

Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic solutions. The Company's segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). Its BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research and development solutions in chemical research fields. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and others.

What is the price predicton of BRKR Stock?

Wall Street analysts forecast BRKR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BRKR is52.18 USD with a low forecast of 40.00 USD and a high forecast of 60.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Bruker Corp (BRKR)'s revenue for the last quarter?

Bruker Corp revenue for the last quarter amounts to 977.20M USD, decreased -0.24

What is Bruker Corp (BRKR)'s earnings per share (EPS) for the last quarter?

Bruker Corp. EPS for the last quarter amounts to 0.10 USD, increased 11.11

How many employees does Bruker Corp (BRKR). have?

Bruker Corp (BRKR) has 11085 emplpoyees as of April 21 2026.

What is Bruker Corp (BRKR) market cap?

Today BRKR has the market capitalization of 6.26B USD.